RESPECT-MESO: AN INTERNATIONAL MULTICENTRE NON-BLINDED RANDOMIZED CONTROLLED TRIAL TO ASSESS THE IMPACT OF REGULAR EARLY SPECIALIST PALLIATIVE CARE IN MALIGNANT PLEURAL MESOTHELIOMA
| Main Authors: | Brims, Fraser, Guntilake, S., Lawrie, I., Marshall, L., Fogg, C., Maskell, N., Forbes, K., Rahman, N., Morris, S., Gerry, S., Chauhan, A. |
|---|---|
| Format: | Conference Paper |
| Published: |
WILEY
2017
|
| Online Access: | http://hdl.handle.net/20.500.11937/65758 |
Similar Items
A randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma - 'RESPECT-Meso'
by: Brims, Fraser, et al.
Published: (2018)
by: Brims, Fraser, et al.
Published: (2018)
Early specialist palliative care on quality of life for malignant pleural mesothelioma: A randomised controlled trial
by: Brims, Fraser, et al.
Published: (2019)
by: Brims, Fraser, et al.
Published: (2019)
A multicentre non-blinded randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma (RESPECT-MESO): Study protocol for a randomised controlled trial
by: Gunatilake, S., et al.
Published: (2014)
by: Gunatilake, S., et al.
Published: (2014)
Prognostic factors for malignant pleural mesothelioma
by: Brims, Fraser, et al.
Published: (2013)
by: Brims, Fraser, et al.
Published: (2013)
Epidemiology of Malignant Pleural Mesothelioma in Australia
by: De Klerk, N., et al.
Published: (2016)
by: De Klerk, N., et al.
Published: (2016)
Asbestos Related non-Malignant Pleural Disease and Mesothelioma
by: Musk, B., et al.
Published: (2016)
by: Musk, B., et al.
Published: (2016)
Postmortem findings of malignant pleural mesothelioma: A two-center study of 318 patients
by: Finn, R., et al.
Published: (2012)
by: Finn, R., et al.
Published: (2012)
A novel clinical prediction model for prognosis in malignant pleural mesothelioma using decision tree analysis
by: Brims, Fraser, et al.
Published: (2016)
by: Brims, Fraser, et al.
Published: (2016)
Palliative care in mesothelioma
by: Brims, Fraser
Published: (2018)
by: Brims, Fraser
Published: (2018)
ROUTINELY COLLECTED CLINICAL AND LABORATORY DATA CAN RELIABLY PREDICT LONGER SURVIVAL IN MALIGNANT PLEURAL MESOTHELIOMA
by: Brims, Fraser, et al.
Published: (2014)
by: Brims, Fraser, et al.
Published: (2014)
Routinely Collected Clinical And Laboratory Data Can Reliably Predict Longer Survival In Malignant Pleural Mesothelioma
by: Brims, Fraser, et al.
Published: (2014)
by: Brims, Fraser, et al.
Published: (2014)
Prediction modelling using routine clinical parameters to stratify survival in Malignant Pleural Mesothelioma patients undergoing cytoreductive surgery.
by: Harris, E., et al.
Published: (2018)
by: Harris, E., et al.
Published: (2018)
Body composition and nutritional status in malignant pleural mesothelioma: implications for activity levels and quality of life.
by: Jeffery, E., et al.
Published: (2019)
by: Jeffery, E., et al.
Published: (2019)
Asbestos exposure and histological subtype of malignant mesothelioma
by: Franklin, P., et al.
Published: (2016)
by: Franklin, P., et al.
Published: (2016)
Protocol of the Australasian Malignant Pleural Effusion-2 (AMPLE-2) trial: A multicentre randomised study of aggressive versus symptom-guided drainage via indwelling pleural catheters
by: Azzopardi, M., et al.
Published: (2016)
by: Azzopardi, M., et al.
Published: (2016)
Predicting survival in malignant mesothelioma
by: Musk, A., et al.
Published: (2011)
by: Musk, A., et al.
Published: (2011)
Incidence of malignant mesothelioma in Aboriginal people in Western Australia.
by: Franklin, P., et al.
Published: (2016)
by: Franklin, P., et al.
Published: (2016)
Wnt Signalling in Malignant Mesothelioma
by: Richards, Alexander S.K.
Published: (2016)
by: Richards, Alexander S.K.
Published: (2016)
Risk factors for malignant mesothelioma in people with no known exposure to asbestos
by: Musk, B., et al.
Published: (2017)
by: Musk, B., et al.
Published: (2017)
Serum mesothelin for early detection of asbestos-induced cancer malignant mesothelioma
by: Creaney, J., et al.
Published: (2010)
by: Creaney, J., et al.
Published: (2010)
Comparison of outcomes following a cytological or histological diagnosis of malignant mesothelioma
by: Muruganandan, S., et al.
Published: (2017)
by: Muruganandan, S., et al.
Published: (2017)
Validation of an Asbestos Job-Exposure Matrix: Exposure-Response Relationships for Malignant Mesothelioma
by: Kamiya, H., et al.
Published: (2018)
by: Kamiya, H., et al.
Published: (2018)
Absence of germline mutations in BAP1 in sporadic cases of malignant mesothelioma
by: Sneddon, S., et al.
Published: (2015)
by: Sneddon, S., et al.
Published: (2015)
Pattern of malignant mesothelioma incidence and occupational exposure to asbestos in Western Australia.
by: Musk, A., et al.
Published: (2015)
by: Musk, A., et al.
Published: (2015)
Asbestos Related Pleural Diseases
by: Brims, Fraser, et al.
Published: (2016)
by: Brims, Fraser, et al.
Published: (2016)
Familial aggregation of malignant mesothelioma in former workers and residents of Wittenoom, Western Australia
by: De Klerk, N., et al.
Published: (2013)
by: De Klerk, N., et al.
Published: (2013)
A genome-wide association study for malignant mesothelioma risk
by: Cadby, G., et al.
Published: (2013)
by: Cadby, G., et al.
Published: (2013)
Increasing incidence of malignant mesothelioma after exposure to asbestos during home maintenance and renovation
by: Olsen, N., et al.
Published: (2011)
by: Olsen, N., et al.
Published: (2011)
MESOTHELIOMA IN AUSTRALIA-RESULTS FROM THE AUSTRALIAN MESOTHELIOMA REGISTRY
by: Sim, M., et al.
Published: (2016)
by: Sim, M., et al.
Published: (2016)
Mesothelioma in australia: A review
by: Musk, A., et al.
Published: (2017)
by: Musk, A., et al.
Published: (2017)
Expression profile and function of Wnt signaling mechanisms in malignant mesothelioma cells
by: Fox, Simon, et al.
Published: (2013)
by: Fox, Simon, et al.
Published: (2013)
Feasibility of objectively measured physical activity and sedentary behavior in patients with malignant pleural effusion
by: Jeffery, E., et al.
Published: (2017)
by: Jeffery, E., et al.
Published: (2017)
Induction of apoptosis in murine malignant mesothelioma cell lines: gene expression and susceptibility
by: Kusmiaty
Published: (2003)
by: Kusmiaty
Published: (2003)
Characterisation of genes derived from murine malignant mesothelioma by suppression subtractive hybridization
by: Thean, Ai Lee
Published: (2002)
by: Thean, Ai Lee
Published: (2002)
Paramedics’ perceptions and educational needs with respect to palliative care
by: Rogers, I., et al.
Published: (2015)
by: Rogers, I., et al.
Published: (2015)
Predicted mortality from malignant mesothelioma among women exposed to blue asbestos at Wittenoom, Western Australia
by: Reid, Alison, et al.
Published: (2009)
by: Reid, Alison, et al.
Published: (2009)
The role of pleural fluid analysis, pleural biopsy and bronchoscopy in neoplastic and tuberculous pleural effusion
by: How, Soon Hin, et al.
Published: (2004)
by: How, Soon Hin, et al.
Published: (2004)
Rapid pleurodesis using small bore pigtail catheter and bleomycin in malignant pleural effusions: a case series
by: Md Hashim , Mohd Nizam
Published: (2009)
by: Md Hashim , Mohd Nizam
Published: (2009)
How integrated are neurology and palliative care services? Results of a multicentre mapping exercise
by: van Vliet, Liesbeth M., et al.
Published: (2016)
by: van Vliet, Liesbeth M., et al.
Published: (2016)
Specialist Palliative Care Use for People Dying of Cancer in Western Australia
by: McNamara, B., et al.
Published: (2007)
by: McNamara, B., et al.
Published: (2007)
Similar Items
-
A randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma - 'RESPECT-Meso'
by: Brims, Fraser, et al.
Published: (2018) -
Early specialist palliative care on quality of life for malignant pleural mesothelioma: A randomised controlled trial
by: Brims, Fraser, et al.
Published: (2019) -
A multicentre non-blinded randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma (RESPECT-MESO): Study protocol for a randomised controlled trial
by: Gunatilake, S., et al.
Published: (2014) -
Prognostic factors for malignant pleural mesothelioma
by: Brims, Fraser, et al.
Published: (2013) -
Epidemiology of Malignant Pleural Mesothelioma in Australia
by: De Klerk, N., et al.
Published: (2016)